The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 17, 2017

Filed:

Oct. 31, 2014
Applicant:

The Board of Trustees of the University of Illinois, Urbana, IL (US);

Inventors:

Jianjun Cheng, Champaign, IL (US);

Rong Tong, Urbana, IL (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C08G 63/82 (2006.01); A61K 47/48 (2006.01); C08G 81/00 (2006.01); A61K 31/337 (2006.01); A61K 31/704 (2006.01); A61K 38/09 (2006.01); A61K 9/51 (2006.01); A61K 38/13 (2006.01); A61K 31/4355 (2006.01);
U.S. Cl.
CPC ...
A61K 47/482 (2013.01); A61K 9/5146 (2013.01); A61K 9/5192 (2013.01); A61K 31/337 (2013.01); A61K 31/4355 (2013.01); A61K 31/704 (2013.01); A61K 38/09 (2013.01); A61K 38/13 (2013.01); A61K 47/48215 (2013.01); A61K 47/48407 (2013.01); A61K 47/48584 (2013.01); A61K 47/48669 (2013.01); A61K 47/48876 (2013.01); A61K 47/48907 (2013.01); A61K 47/48915 (2013.01); C08G 63/823 (2013.01); C08G 81/00 (2013.01);
Abstract

Methods for efficient preparation of drug-polymer (or oligomer) conjugates useful in the preparation of particles, including microparticles and nanoparticles, for delivery of the drug in vivo for therapeutic applications are provided. The invention also provides nanoparticles prepared by nanoprecipitation using drug-polymer/oligomer conjugates of the invention. The drug conjugates are formed during polymerization of the polymer or oligomer in which the drug is employed as an initiator of the polymerization of the monomers which form the polymer and/or oligomer. More specifically, the drug conjugates are formed by ring-opening polymerization of cyclic monomers in the presence of an appropriate ring-opening polymerization catalyst and the initiator (the drug). The method is particularly useful for formation of polymer/oligomer conjugates with drugs and other chemical species containing one or more hydroxyl groups or thiol groups.


Find Patent Forward Citations

Loading…